A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Children's Oncology Group
University of Colorado, Denver
Ohio State University Comprehensive Cancer Center
Geneve TEAM Ambulances
Hospital Universitario Dr. Jose E. Gonzalez
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
Group for Research in Adult Acute Lymphoblastic Leukemia
Gamida Cell ltd
Bristol-Myers Squibb
Dana-Farber Cancer Institute
Institute of Hematology & Blood Diseases Hospital, China
National Research Center for Hematology, Russia
H. Lee Moffitt Cancer Center and Research Institute
Danone Asia Pacific Holdings Pte, Ltd.
AIDS Malignancy Consortium
Children's Hospital Los Angeles
University of Iowa
Children's Hospital of Philadelphia
Newave Pharmaceutical Inc
CHU de Reims
University of Nebraska
M.D. Anderson Cancer Center
University of Pittsburgh
Center for International Blood and Marrow Transplant Research
University Hospital, Lille
Goethe University
H. Lee Moffitt Cancer Center and Research Institute
Pfizer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Pfizer
National Cancer Institute (NCI)
University of Arizona
SF Research Institute, Inc.
St. Jude Children's Research Hospital
Therapeutic Advances in Childhood Leukemia Consortium
Dana-Farber Cancer Institute
American University of Beirut Medical Center
Wugen, Inc.
Gazi University
University of Florida
McMaster University
Near East University, Turkey
Atlas University
Akdeniz University
Stanford University
Center for International Blood and Marrow Transplant Research